-
1مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link -
3مورد إلكتروني
مصطلحات الفهرس: childhood disease/di [Diagnosis], article, blood vessel diameter, central nervous system disease/di [Diagnosis], central nervous system disease/dt [Drug Therapy], child, childhood disease/dt [Drug Therapy], cognitive defect, controlled study, data base, disease burden, disease severity, female, functional assessment, human, intellectual impairment/di [Diagnosis], major clinical study, male, memory disorder/di [Diagnosis], multicenter study (topic), neuroimaging, neuropsychological test, nuclear magnetic resonance imaging, onset age, outcome assessment, phenotype, preschool child, priority journal, retrospective study, school child, scoring system, seizure, symptom, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], Wechsler intelligence scale for children, working memory, antibiotic agent, anticonvulsive agent, azathioprine/dt [Drug Therapy], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], mycophenolate mofetil/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], psychotropic agent, childhood primary central nervous system vasculitis/di [Diagnosis], childhood primary central nervous system vasculitis/dt [Drug Therapy], Full Scale IQ score, Verbal Comprehension and Perceptual Reasoning index score, Working Memory and Processing Speed index score, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36142
Neuropsychology
Click here for full text options
LibKey Link -
4مورد إلكتروني
مصطلحات الفهرس: childhood disease/di [Diagnosis], article, blood vessel diameter, central nervous system disease/di [Diagnosis], central nervous system disease/dt [Drug Therapy], child, childhood disease/dt [Drug Therapy], cognitive defect, controlled study, data base, disease burden, disease severity, female, functional assessment, human, intellectual impairment/di [Diagnosis], major clinical study, male, memory disorder/di [Diagnosis], multicenter study (topic), neuroimaging, neuropsychological test, nuclear magnetic resonance imaging, onset age, outcome assessment, phenotype, preschool child, priority journal, retrospective study, school child, scoring system, seizure, symptom, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], Wechsler intelligence scale for children, working memory, antibiotic agent, anticonvulsive agent, azathioprine/dt [Drug Therapy], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], mycophenolate mofetil/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], psychotropic agent, childhood primary central nervous system vasculitis/di [Diagnosis], childhood primary central nervous system vasculitis/dt [Drug Therapy], Full Scale IQ score, Verbal Comprehension and Perceptual Reasoning index score, Working Memory and Processing Speed index score, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36142
Neuropsychology
LibKey Link -
5مورد إلكتروني
مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
Click here for full text options
LibKey Link -
6مورد إلكتروني
مصطلحات الفهرس: infection, kidney disease, macrophage, maintenance therapy, microscopic polyangiitis, monocyte, neutrophil, nonhuman, pathogenesis, pathophysiology, prevalence, priority journal, prognosis, quality of life, respiratory tract disease, review, risk factor, screening, T lymphocyte, treatment duration, Wegener granulomatosis/dt [Drug Therapy], Wegener granulomatosis/et [Etiology], autoantigen/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], cyclophosphamide/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunomodulating agent/dt [Drug Therapy], immunosuppressive agent/dt [Drug Therapy], mepolizumab/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], rituximab/dt [Drug Therapy], eosinophilic granulomatosis with polyangiitis/dt [Drug Therapy], microvasculature, ANCA associated vasculitis/di [Diagnosis], ANCA associated vasculitis/dm [Disease Management], ANCA associated vasculitis/dt [Drug Therapy], ANCA associated vasculitis/ep [Epidemiology], ANCA associated vasculitis/et [Etiology], ANCA associated vasculitis/pc [Prevention], B lymphocyte, biopsy, cardiovascular disease, cellular immunity, clinical feature, clinical trial (topic), comorbidity, complement activation, diagnostic imaging, disease activity, disease association, disease classification, disease severity, environmental factor, genetics, human, incidence, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29087
Click here for full text options
LibKey Link -
7مورد إلكتروني
مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
LibKey Link -
8مورد إلكتروني
مصطلحات الفهرس: infection, kidney disease, macrophage, maintenance therapy, microscopic polyangiitis, monocyte, neutrophil, nonhuman, pathogenesis, pathophysiology, prevalence, priority journal, prognosis, quality of life, respiratory tract disease, review, risk factor, screening, T lymphocyte, treatment duration, Wegener granulomatosis/dt [Drug Therapy], Wegener granulomatosis/et [Etiology], autoantigen/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], cyclophosphamide/dt [Drug Therapy], glucocorticoid/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunomodulating agent/dt [Drug Therapy], immunosuppressive agent/dt [Drug Therapy], mepolizumab/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], rituximab/dt [Drug Therapy], eosinophilic granulomatosis with polyangiitis/dt [Drug Therapy], microvasculature, ANCA associated vasculitis/di [Diagnosis], ANCA associated vasculitis/dm [Disease Management], ANCA associated vasculitis/dt [Drug Therapy], ANCA associated vasculitis/ep [Epidemiology], ANCA associated vasculitis/et [Etiology], ANCA associated vasculitis/pc [Prevention], B lymphocyte, biopsy, cardiovascular disease, cellular immunity, clinical feature, clinical trial (topic), comorbidity, complement activation, diagnostic imaging, disease activity, disease association, disease classification, disease severity, environmental factor, genetics, human, incidence, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29087
Nature Reviews Disease Primers
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: cyclophosphamide, follicular lymphoma/dt [Drug Therapy], fludarabine, Fc receptor/ec [Endogenous Compound], cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine, acute lymphoblastic leukemia/dt [Drug Therapy], amino acid sequence, ANCA associated vasculitis/dt [Drug Therapy], antigen binding, antineoplastic activity, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer immunization, cell killing, chronic lymphatic leukemia/dt [Drug Therapy], clinical trial (topic), complement dependent cytotoxicity, diffuse large B cell lymphoma/dt [Drug Therapy], down regulation, drug mechanism, drug receptor binding, event free survival, hematologic malignancy/dt [Drug Therapy], human, humoral immune deficiency/dt [Drug Therapy], idiopathic thrombocytopenic purpura/dt [Drug Therapy], immune response, immunomodulation, immunosuppressive treatment, lack of drug effect, leukemia/si [Side Effect], lymphocytic lymphoma/dt [Drug Therapy], lymphoproliferative disease/dt [Drug Therapy], marginal zone lymphoma/dt [Drug Therapy], molecularly targeted therapy, overall survival, partial drug response, pharmacokinetic parameters, progression free survival, protein degradation, protein expression, randomized controlled trial (topic), methotrexate, obinutuzumab/dt [Drug Therapy], ocrelizumab, ofatumumab/dt [Drug Therapy], rituximab/ae [Adverse Drug Reaction], rituximab/dt [Drug Therapy], tumor antigen/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], veltuzumab, CD20 antibody, B lymphocyte receptor/ec [Endogenous Compound], systemic lupus erythematosus/dt [Drug Therapy], smoldering multiple myeloma/dt [Drug Therapy], rheumatoid arthritis/dt [Drug Therapy], review, recombinant DNA technology, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36922
Human Vaccines and Immunotherapeutics
Click here for full text options
LibKey Link -
10مورد إلكتروني
مصطلحات الفهرس: cyclophosphamide, follicular lymphoma/dt [Drug Therapy], fludarabine, Fc receptor/ec [Endogenous Compound], cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine, acute lymphoblastic leukemia/dt [Drug Therapy], amino acid sequence, ANCA associated vasculitis/dt [Drug Therapy], antigen binding, antineoplastic activity, B cell lymphoma/dt [Drug Therapy], Burkitt lymphoma/dt [Drug Therapy], cancer immunization, cell killing, chronic lymphatic leukemia/dt [Drug Therapy], clinical trial (topic), complement dependent cytotoxicity, diffuse large B cell lymphoma/dt [Drug Therapy], down regulation, drug mechanism, drug receptor binding, event free survival, hematologic malignancy/dt [Drug Therapy], human, humoral immune deficiency/dt [Drug Therapy], idiopathic thrombocytopenic purpura/dt [Drug Therapy], immune response, immunomodulation, immunosuppressive treatment, lack of drug effect, leukemia/si [Side Effect], lymphocytic lymphoma/dt [Drug Therapy], lymphoproliferative disease/dt [Drug Therapy], marginal zone lymphoma/dt [Drug Therapy], molecularly targeted therapy, overall survival, partial drug response, pharmacokinetic parameters, progression free survival, protein degradation, protein expression, randomized controlled trial (topic), methotrexate, obinutuzumab/dt [Drug Therapy], ocrelizumab, ofatumumab/dt [Drug Therapy], rituximab/ae [Adverse Drug Reaction], rituximab/dt [Drug Therapy], tumor antigen/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], veltuzumab, CD20 antibody, B lymphocyte receptor/ec [Endogenous Compound], systemic lupus erythematosus/dt [Drug Therapy], smoldering multiple myeloma/dt [Drug Therapy], rheumatoid arthritis/dt [Drug Therapy], review, recombinant DNA technology, Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36922
Human Vaccines and Immunotherapeutics
LibKey Link